van Rees, G. F. Et Al. 2018. Evidence of microglial activation following exposure to serum from first-onset drug-naive schizophrenia patients. BRAIN BEHAVIOR AND IMMUNITY , vol.67 , 364-373.

van Rees, G. F., Lago, S. G., Cox, D. A., Tomasik, J., Rustogi, N., Weigelt, K., ... Ozcan, S.(2018). Evidence of microglial activation following exposure to serum from first-onset drug-naive schizophrenia patients. BRAIN BEHAVIOR AND IMMUNITY , vol.67, 364-373.

van Rees, Geertje Et Al. "Evidence of microglial activation following exposure to serum from first-onset drug-naive schizophrenia patients," BRAIN BEHAVIOR AND IMMUNITY , vol.67, 364-373, 2018

van Rees, Geertje F. Et Al. "Evidence of microglial activation following exposure to serum from first-onset drug-naive schizophrenia patients." BRAIN BEHAVIOR AND IMMUNITY , vol.67, pp.364-373, 2018

van Rees, G. F. Et Al. (2018) . "Evidence of microglial activation following exposure to serum from first-onset drug-naive schizophrenia patients." BRAIN BEHAVIOR AND IMMUNITY , vol.67, pp.364-373.

@article{article, author={Geertje Frederique van Rees Et Al. }, title={Evidence of microglial activation following exposure to serum from first-onset drug-naive schizophrenia patients}, journal={BRAIN BEHAVIOR AND IMMUNITY}, year=2018, pages={364-373} }